Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent ‘type I’ mode

Bernhard Gillissen, P T Daniel|Cell Death and Disease|2013

Cited by 46